Relay Therapeutics, Inc. (RLAY)
18.08
-1.64
(-8.32%)
USD |
NASDAQ |
Nov 12, 16:00
17.78
-0.30
(-1.66%)
After-Hours: 06:39
Relay Therapeutics Market Cap : 3.969B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.969B |
| November 11, 2026 | 4.329B |
| November 10, 2026 | 4.377B |
| November 09, 2026 | 4.476B |
| November 06, 2026 | 4.083B |
| November 05, 2026 | 3.732B |
| November 04, 2026 | 3.958B |
| November 03, 2026 | 3.828B |
| November 02, 2026 | 3.793B |
| October 30, 2026 | 4.010B |
| October 29, 2026 | 4.255B |
| October 28, 2026 | 4.303B |
| October 27, 2026 | 4.117B |
| October 26, 2026 | 3.960B |
| October 23, 2026 | 3.973B |
| October 22, 2026 | 4.008B |
| October 21, 2026 | 4.023B |
| October 20, 2026 | 4.032B |
| October 19, 2026 | 3.735B |
| October 16, 2026 | 3.558B |
| October 15, 2026 | 3.781B |
| October 14, 2026 | 3.728B |
| October 13, 2026 | 3.794B |
| October 12, 2026 | 3.929B |
| October 09, 2026 | 3.907B |
| Date | Value |
|---|---|
| October 08, 2026 | 3.805B |
| October 07, 2026 | 3.923B |
| October 06, 2026 | 4.095B |
| October 05, 2026 | 4.237B |
| October 02, 2026 | 4.143B |
| October 01, 2026 | 4.041B |
| September 30, 2026 | 3.944B |
| September 29, 2026 | 4.012B |
| September 28, 2026 | 3.866B |
| September 25, 2026 | 3.818B |
| September 24, 2026 | 3.875B |
| September 23, 2026 | 3.940B |
| September 22, 2026 | 4.229B |
| September 21, 2026 | 3.975B |
| September 18, 2026 | 4.117B |
| September 17, 2026 | 4.194B |
| September 16, 2026 | 4.117B |
| September 15, 2026 | 4.146B |
| September 14, 2026 | 4.165B |
| September 11, 2026 | 4.124B |
| September 10, 2026 | 4.128B |
| September 09, 2026 | 4.078B |
| September 08, 2026 | 4.176B |
| September 04, 2026 | 4.161B |
| September 03, 2026 | 4.154B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 1.621B |
| TG Therapeutics, Inc. | 9.759B |
| Spyre Therapeutics, Inc. | 9.257B |
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
Market Cap Related Metrics
| PS Ratio | 338.57 |
| Price to Book Value | 4.846 |
| Price | 18.08 |
| Earnings Yield | -8.35% |